ArticleExperimental & molecular medicine2025
Discovery of ETI41 and ETI60: novel selective endosomal Toll-like receptor inhibitors for the treatment of autoimmune diseases.
Uisuk Jeong et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.